One Platform Instead of Two Steps
According to a joint statement, eligible patients prescribed by a licensed provider on Hims & Hers can complete a consultation, receive a prescription if their provider deems it appropriate and have the medicine shipped to their home without leaving the platform. The key terms of the deal include:
- Self-pay prices start at $149 a month for Foundayo and $299 a month for Zepbound, the same as on LillyDirect.
- On the same platform, Novo’s drugs start at $149 a month for the Wegovy pill and $199 a month for the Wegovy injector pen.
- Hims & Hers has committed not to sell any compounded versions or knockoffs of Lilly’s obesity medicines.
Meeting patients where they already are.
Leveling the Race With Novo Nordisk
Novo Nordisk has sold Wegovy and Ozempic through Hims & Hers since March, after previously suing the telehealth company for offering compounded versions of its drugs. Leerink Partners analyst Michael Cherny said the Lilly deal completes Hims & Hers’ effort to secure access to both leading GLP-1 makers, broadening access to branded treatments after the company’s exit from mass compounding.

















